Nathan Mcclure, LSW, MSW, LCSWI | |
500 Youth Center Drive, Caliente, NV 89008 | |
(775) 726-8214 | |
Not Available |
Full Name | Nathan Mcclure |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 500 Youth Center Drive, Caliente, Nevada |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780977561 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 5192-S (Nevada) | Primary |
Entity Name | State Of Nevada |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760572010 PECOS PAC ID: 9234022153 Enrollment ID: O20040212000160 |
News Archive
China Nuvo Solar Energy, Inc. today announced that its wholly owned subsidiary, SurgLine will deliver its first surgical instrumentation products to one of Denver's largest acute care hospital systems for use by one of its outpatient surgery centers.
"Republicans were withering in their criticism of what they deemed a budget-busting government takeover," NPR reports. "Senate Minority Leader Mitch McConnell of Kentucky blasted the bill, saying it 'fails to lower costs.'" He said Republicans would continue to battle the legislation.
A recent questionnaire submitted to a group of patients at one of the nation's largest general hospitals suggests that a significant number of patients, who have previously refused colorectal cancer screening, are willing to undergo computed tomography colonography (CTC) (or virtual colonoscopy), but not willing to pay for the exam themselves when not covered by insurance, according to a study in the August issue of the American Journal of Roentgenology (www.ajronline.org).
Five Star Quality Care, Inc. today announced that it has been added to the broad market Russell 3000® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and global equity indexes on June 25, 2010. The Russell 3000 Index also serves as the U.S. component to the Russell Global Index.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies, announced today the results of a healthy volunteers Phase I clinical study of Bendavia™, a novel compound that targets the mitochondrion to treat ischemia reperfusion injury.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Nathan Mcclure, LSW, MSW, LCSWI 500 Youth Center Drive, Caliente, NV 89008 Ph: (775) 726-8214 | Nathan Mcclure, LSW, MSW, LCSWI 500 Youth Center Drive, Caliente, NV 89008 Ph: (775) 726-8214 |
News Archive
China Nuvo Solar Energy, Inc. today announced that its wholly owned subsidiary, SurgLine will deliver its first surgical instrumentation products to one of Denver's largest acute care hospital systems for use by one of its outpatient surgery centers.
"Republicans were withering in their criticism of what they deemed a budget-busting government takeover," NPR reports. "Senate Minority Leader Mitch McConnell of Kentucky blasted the bill, saying it 'fails to lower costs.'" He said Republicans would continue to battle the legislation.
A recent questionnaire submitted to a group of patients at one of the nation's largest general hospitals suggests that a significant number of patients, who have previously refused colorectal cancer screening, are willing to undergo computed tomography colonography (CTC) (or virtual colonoscopy), but not willing to pay for the exam themselves when not covered by insurance, according to a study in the August issue of the American Journal of Roentgenology (www.ajronline.org).
Five Star Quality Care, Inc. today announced that it has been added to the broad market Russell 3000® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and global equity indexes on June 25, 2010. The Russell 3000 Index also serves as the U.S. component to the Russell Global Index.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies, announced today the results of a healthy volunteers Phase I clinical study of Bendavia™, a novel compound that targets the mitochondrion to treat ischemia reperfusion injury.
› Verified 9 days ago